MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2022-11-15
相关数据集
Molecular Signatures Associated with Prolonged Survival In Melanoma Patients Treated with Dendritic Cell-Based Immunotherapy
Analysis of gene expression dynamics in patients suffering from melanoma stage IV treated with vaccination therapy. Total RNA extracted from blood samples prior to first vaccination, at time points of
NIAID Data Ecosystem440
Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: A projected basis for immunotherapy
Melanomas tend to become less pigmented in the course of malignant progression. Thus, as proliferation increases, the tumors are decreasingly characterized by the tissue-specific phenotype of normally
PubMed Central1997-05-13 更新90
Supplementation with a-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1
Patients with advanced melanoma have shown an improved outlook after receiving anti-PD1 therapy, but the low response rate restricts clinical benefit; therefore, enhancing anti-PD1 therapy efficacy re
NIAID Data Ecosystem70
table_1_Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report.PDF
The allogeneic therapeutic vaccine CSF-470 has demonstrated a significant benefit over medium-dose IFNα2b in the distant metastasis-free survival for stages IIB–IIC–III cutaneous melanoma patients in
NIAID Data Ecosystem240
IFNγ treatment restores TAP-dependent presentation competence of PD-L1 sensitive PDAC cells. IFNγ treatment restores TAP-dependent presentation competence of PD-L1 sensitive PDAC cells
For immunotherapy, there is an urgent need to restore presentation-competence of cancer cells with defects in MHC-I processing/presentation. We identified two tumor-specific antigens expressed in the
NIAID Data Ecosystem80
